Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study)

PubWeight™: 2.42‹?› | Rank: Top 2%

🔗 View Article (PMC 2352363)

Published in BMJ on October 26, 1996

Authors

S Kiechl1, J Willeit, W Poewe, G Egger, F Oberhollenzer, M Muggeo, E Bonora

Author Affiliations

1: Department of Neurology, University of Innsbruck, Austria.

Articles citing this

The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction (2010) 5.14

Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ (1999) 4.14

Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart (1997) 2.50

Psychosocial, lifestyle, and health status variables in predicting high attendance among adults. Br J Gen Pract (2001) 1.76

Joint association of glycemic load and alcohol intake with type 2 diabetes incidence in women. Am J Clin Nutr (2011) 1.63

Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer (2014) 1.38

Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study. Am J Clin Nutr (2008) 1.27

Chronic diseases and conditions related to alcohol use. Alcohol Res (2013) 1.24

The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry. J Gen Intern Med (2008) 1.21

Coffee, tea, and alcohol intake in relation to risk of type 2 diabetes in African American women. Am J Clin Nutr (2010) 1.12

Alcohol consumption and the incidence of type II diabetes. J Epidemiol Community Health (2002) 1.10

The association of alcohol consumption with coronary heart disease mortality and cancer incidence varies by smoking history. J Gen Intern Med (2005) 1.09

Lifestyle factors and risk for new-onset diabetes: a population-based cohort study. Ann Intern Med (2011) 1.09

Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol (2012) 1.08

The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci (2005) 1.06

Insulin resistance. BMJ (1996) 1.00

The preventable proportion of type 2 diabetes by ethnicity: the multiethnic cohort. Ann Epidemiol (2011) 0.99

Moderate alcohol consumption and coronary heart disease: a review. Postgrad Med J (2001) 0.97

Alcohol consumption and risk of all-cause and cardiovascular disease mortality in men. J Aging Res (2011) 0.93

Long-term alcohol consumption in relation to all-cause and cardiovascular mortality among survivors of myocardial infarction: the Health Professionals Follow-up Study. Eur Heart J (2012) 0.92

Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus. Metabolism (2008) 0.90

Alcohol consumption improves insulin signaling in the myocardium. Surgery (2013) 0.89

Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions. Pharmacol Ther (2008) 0.89

Alcohol consumption and diabetes risk in the Diabetes Prevention Program. Am J Clin Nutr (2009) 0.89

Wine drinking is associated with increased heart rate variability in women with coronary heart disease. Heart (2005) 0.89

Dietary insulin index and insulin load in relation to biomarkers of glycemic control, plasma lipids, and inflammation markers. Am J Clin Nutr (2011) 0.89

Alcoholic beverages and risk of renal cell cancer. Br J Cancer (2007) 0.88

Short-term red wine consumption promotes differential effects on plasma levels of high-density lipoprotein cholesterol, sympathetic activity, and endothelial function in hypercholesterolemic, hypertensive, and healthy subjects. Clinics (Sao Paulo) (2009) 0.87

Temporal effects of ethanol consumption on energy homeostasis, hepatic steatosis, and insulin sensitivity in mice. Alcohol Clin Exp Res (2013) 0.86

Fluid intake and incidence of renal cell carcinoma in UK women. Br J Cancer (2011) 0.85

A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase. World J Gastroenterol (2009) 0.84

Alcohol drinking patterns and the risk of fatty liver in Japanese men. J Gastroenterol (2010) 0.83

Impact of Alcohol on Glycemic Control and Insulin Action. Biomolecules (2015) 0.83

Moderate alcohol consumption has been shown previously to improve insulin sensitivity in men. BMJ (1997) 0.82

Alcohol drinking may not be a major risk factor for fatty liver in Japanese undergoing a health checkup. Dig Dis Sci (2009) 0.81

Relationship between metabolic syndrome and familial history of hypertension/stroke, diabetes, and cardiovascular disease. J Korean Med Sci (2006) 0.81

Low fasting serum insulin in Japanese alcohol consumers does not imply improved coronary risk factors. Environ Health Prev Med (2004) 0.78

Alcohol consumption and the risk of coronary heart disease in postmenopausal women with diabetes: Women's Health Initiative Observational Study. Eur J Nutr (2009) 0.77

Alcohol Consumption and Risk of Breast Cancer by Tumor Receptor Expression. Horm Cancer (2015) 0.76

Beneficial effects of ethanol consumption on insulin resistance are only applicable to subjects without obesity or insulin resistance; drinking is not necessarily a remedy for metabolic syndrome. Int J Environ Res Public Health (2011) 0.75

Relation of insulin resistance with social-demographics, adiposity and behavioral factors in non-diabetic adult Canadians. J Diabetes Metab Disord (2016) 0.75

Acute effects of traditional Japanese alcohol beverages on blood glucose and polysomnography levels in healthy subjects. PeerJ (2016) 0.75

Consumption of Chinese tea-flavor liquor improves circulating insulin levels without affecting hepatic lipid metabolism-related gene expression in Sprague-Dawley rats. ScientificWorldJournal (2013) 0.75

Case-Based Reasoning for Insulin Bolus Advice. J Diabetes Sci Technol (2016) 0.75

Articles cited by this

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13

Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22

Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13

Immunoassay of insulin with insulin-antibody precipitate. Biochem J (1963) 17.13

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med (1993) 6.89

Assessment of insulin sensitivity in vivo. Endocr Rev (1985) 4.21

Drug-induced disorders of glucose tolerance. Ann Intern Med (1993) 4.18

Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med (1991) 3.58

Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes (1992) 3.27

How good a marker is insulin level for insulin resistance? Am J Epidemiol (1993) 2.18

Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care (1980) 1.98

Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl (1985) 1.52

Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care (1994) 1.44

Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. Arteriosclerosis (1990) 1.19

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia (1991) 1.17

Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation (1993) 1.11

Relationship of hyperinsulinemia to dietary intake in south Asian and European men. Am J Clin Nutr (1994) 1.09

Alcohol consumption and carotid atherosclerosis: evidence of dose-dependent atherogenic and antiatherogenic effects. Results from the Bruneck Study. Stroke (1994) 1.05

Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. Arterioscler Thromb (1993) 1.04

Effects of chronic ethanol consumption in atherosclerosis-prone JCR:LA-corpulent rat. Arteriosclerosis (1989) 1.01

Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb (1991) 0.96

Alcohol consumption and its relation to cardiovascular risk factors in British women. BMJ (1992) 0.94

Effect of ethanol and its metabolites on glucose mediated insulin release from isolated islets of rats. Metabolism (1979) 0.93

Potentiation of the plasma insulin response to glucose by prior administration of alcohol. An apparent islet-priming effect. Diabetes (1969) 0.92

Quantitative assessment of carotid atherosclerosis in a healthy population. Neuroepidemiology (1994) 0.91

The effects of chronic ethanol administration on the rates of internalization of various ligands during hepatic endocytosis. Biochim Biophys Acta (1992) 0.90

Alcohol, glucose metabolism and diabetes. Diabetes Metab Rev (1993) 0.89

Effect of ethanol, acetaldehyde, and acetate on insulin and glucagon secretion in the perfused rat pancreas. Diabetes (1981) 0.89

Effects of ethanol on carbohydrate metabolism in the elderly. Diabetes (1993) 0.87

Acute effects of ethanol on hepatic endocytosis and processing of insulin in perfused rat liver. Am J Physiol (1993) 0.82

Effect of alcohol on glucose tolerance in normal and noninsulin-dependent diabetic subjects. Alcohol Clin Exp Res (1988) 0.82

Evaluation of two insulin assays in insulin resistance syndrome (syndrome X). Arterioscler Thromb (1994) 0.81

Articles by these authors

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care (2000) 9.10

Dissecting obesogenic environments: the development and application of a framework for identifying and prioritizing environmental interventions for obesity. Prev Med (1999) 8.06

Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

An "ecological" approach to the obesity pandemic. BMJ (1997) 5.43

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet (1993) 4.03

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes (1998) 3.55

Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol (1999) 3.44

Preventive strategies against weight gain and obesity. Obes Rev (2002) 3.15

Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation (1999) 3.08

Results of large scale media antismoking campaign in Australia: North Coast "Quit for Life" programme. Br Med J (Clin Res Ed) (1983) 2.97

Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study. Circulation (1999) 2.73

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med (1989) 2.63

Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med (1996) 2.45

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab (2000) 2.43

Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry (2002) 2.36

Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation (1997) 2.18

Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. Lancet (2005) 2.18

Burden of atherosclerosis and risk of venous thromboembolism in patients with migraine. Neurology (2008) 2.16

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia (2001) 2.12

Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care (1996) 2.11

Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab (1989) 2.07

Examination of postoperative peripheral nerve lesions with high-resolution sonography. AJR Am J Roentgenol (2001) 1.98

Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med (2008) 1.91

The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med (2004) 1.89

Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care (1999) 1.86

Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care (2001) 1.84

Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation (2000) 1.81

Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology (2005) 1.77

Juvenile asymmetric segmental spinal muscular atrophy (Hirayama's disease): three cases without evidence of "flexion myelopathy". Acta Neurol Scand (2001) 1.74

Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects. J Med Genet (2005) 1.74

Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry (2000) 1.70

Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care (2000) 1.65

FOXP2 is not a major susceptibility gene for autism or specific language impairment. Am J Hum Genet (2002) 1.63

Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest (2001) 1.59

Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord (1996) 1.58

Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. Eur J Neurol (2012) 1.57

Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry (1999) 1.57

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol (2013) 1.52

Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol (2001) 1.52

Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly(A). Nucleic Acids Res (1997) 1.51

The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol (2002) 1.51

Distal myasthenia gravis frequency and clinical course in a large prospective series. Acta Neurol Scand (2003) 1.50

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain (1999) 1.48

Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology (2007) 1.48

Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry (2003) 1.47

Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation (2000) 1.47

Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes (1996) 1.46

Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol (1993) 1.46

Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. Circulation (1999) 1.46

Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology (2002) 1.46

Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Neurology (2008) 1.45

Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest (1995) 1.45

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease. Eur J Neurol (2006) 1.45

Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements? Metabolism (1995) 1.44

Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab (1999) 1.43

Subcutaneous apomorphine in Parkinson's disease. Lancet (1988) 1.41

The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group. Arterioscler Thromb Vasc Biol (1999) 1.40

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia (2007) 1.40

Transient restless legs syndrome after spinal anesthesia: a prospective study. Neurology (2002) 1.39

[Spinal fibrocartilaginous embolism]. Nervenarzt (2005) 1.39

[Vascular parkinsonian syndrome]. Nervenarzt (2006) 1.39

Carotid endarterectomy within seven days after the neurological index event is safe and effective in stroke prevention. Eur J Vasc Endovasc Surg (2011) 1.38

Cortical and brain stem hyperexcitability in striatonigral degeneration. Mov Disord (1998) 1.38

Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors. N Engl J Med (1978) 1.37

The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler Thromb Vasc Biol (1999) 1.35

Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest (1993) 1.34

Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1997) 1.34

Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manage (2000) 1.32